DEF 14A

Company

Praxis Precision Medicines, Inc.

Filed

April 26, 2024

Period of Report

June 5, 2024

Accession Number

0001689548-24-000048

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →